| | |
Number of patients, n (%)
|
Subset with FU, n (%)
|
|---|
|
Total
| |
122 (100.0)
|
77 (100.0)
|
|
Histologic subtype
|
ccRCC
|
86 (70.5)
|
57 (74.0)
|
| |
pap. RCC
|
24 (19.7)
|
17 (22.1)
|
| |
chrom. RCC
|
3 (2.5)
|
2 (2.6)
|
| |
Mixed histology
|
5 (4.1)
|
1 (1.3)
|
| |
Other
|
4 (3.3)
|
0 (0)
|
|
Gender
|
Female
|
43 (35.2)
|
27 (35.1)
|
| |
Male
|
79 (64.8)
|
50 (64.9)
|
|
Age (years)
|
Median
|
64.5
|
65
|
| |
Min-Max
|
35–91
|
37–91
|
|
Metastasis
|
M0
|
95 (77.9)
|
59 (76.6)
|
| |
M1
|
27 (22.1)
|
18 (23.4)
|
| |
NA
|
0 (0.0)
| |
|
Lymph node status
|
N0
|
107 (87.7)
|
70 (90.9)
|
| |
N1
|
15 (12.3)
|
7 (9.1)
|
|
Tumor stage
|
pT1
|
11 (9.0)
|
8 (10.4)
|
| |
pT1a
|
35 (28.7)
|
24 (31.2)
|
| |
pT1b
|
21 (17.2)
|
13 (16.9)
|
| |
pT2
|
8 (6.6)
|
6 (7.8)
|
| |
pT3
|
5 (4.1)
|
2 (2.6)
|
| |
pT3a
|
12 (9.8)
|
4 (5.2)
|
| |
pT3b
|
25 (20.5)
|
18 (23.4)
|
| |
pT3c
|
3 (2.5)
|
2 (2.6)
|
| |
pT4
|
1 (0.8)
|
0 (0.0)
|
| |
NA
|
1 (0.8)
|
0 (0.0)
|
|
Differentiation
|
G1
|
24 (19.7)
|
14 (18.2)
|
| |
G1–2
|
16 (13.1)
|
10 (13.0)
|
| |
G2
|
62 (50.8)
|
42 (54.5)
|
| |
G2–3
|
9 (7.4)
|
5 (6.5)
|
| |
G3
|
11 (9.0)
|
6 (7.8)
|
|
State of disease*
|
Localized
|
65 (53.3)
|
42 (54.5)
|
| |
Advanced
|
56 (45.9)
|
35 (45.5)
|
| |
NA
|
1 (0.8)
|
0 (0.0)
|
- Abbreviations: ccRCC clear cell renal cell carcinoma (RCC); pap. RCC papillary RCC; chrom. RCC chromophobe RCC; FU follow-up; NA not available
- *Localized disease defined as pT ≤ 2, N0, M0; Advanced disease defined as pT ≥ 3 and/or N+, M+
